Semaglutide, the active ingredient in Ozempic, Wegovy, and Rybelsus, has become one of the most discussed medications in Canada in recent years. But headlines tend to focus on weight loss transformations and supply shortages, glossing over much of the practical day-to-day information patients really want to know.
If you have ever wanted to understand how semaglutide actually works, what it is officially approved for in Canada, and how the different available products compare, this ultimate guide is for you.
We’ll break down exactly how semaglutide targets appetite and blood sugar, which brands are available, and where it fits into the broader landscape of GLP-1 treatments. The aim is to give you a clear picture of semaglutide in Canada, then point you to more detailed reading for specific brands or comparisons when you want to dig deeper.
What Is Semaglutide?
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. In plain terms, it’s a synthetic version of a natural hormone your gut releases after meals to help regulate blood sugar and appetite. It was developed by Novo Nordisk and is approved by Health Canada to treat Type 2 diabetes (as Ozempic) and obesity (as Wegovy).
The natural GLP-1 hormone your body produces is broken down within minutes of being released. Semaglutide is engineered to last much longer in the body — roughly a week per injection.
Once active in the body, semaglutide:
- Signals the pancreas to release insulin when blood sugar is high
- Suppresses the release of glucagon (a hormone that raises blood sugar)
- Slows how quickly food leaves the stomach
- Acts on appetite centres in the brain to reduce hunger
In people taking semaglutide, this combination of effects usually results in better blood sugar control (useful for diabetes) and weight loss.
Semaglutide Products Available in Canada
Semaglutide is sold in Canada under three brand names — Ozempic, Wegovy, and Rybelsus. All three contain the same active ingredient, but they have different formulations and are approved for different uses.
Ozempic
Ozempic is a once-weekly semaglutide injection approved by Health Canada to treat Type 2 diabetes. It comes in a multi-dose pen with weekly doses up to 2.0 mg.
Although it’s not approved for weight loss in Canada, Ozempic is widely prescribed off-label for that purpose. For more on Ozempic specifically, see our article on Ozempic for Weight Loss in Canada.
Wegovy
Wegovy is also a once-weekly injection, but it’s the version of semaglutide that’s officially approved in Canada for chronic weight management.
Wegovy uses higher doses than Ozempic, going up to 2.4 mg per week, and is also approved to reduce the risk of major cardiovascular events in adults with established heart disease. Our Wegovy Canada article covers cost, coverage, and how it compares with Ozempic in more detail.
Rybelsus
Unlike Ozempic and Wegovy, Rybelsus is an oral (tablet) formulation of semaglutide that’s taken first thing in the morning on an empty stomach. Rybelsus is the only form of semaglutide tablets approved in Canada, but it’s approved in Canada for Type 2 diabetes only, not weight loss.
The maximum approved dose of Rybelsus is 14 mg daily. This is a much higher dose than the injectable forms of semaglutide, due to the limitations in how the body absorbs semaglutide tablets compared to a direct injection.
You can read our article on Rybelsus for more information.
Semaglutide for Weight Loss in Canada
The growing interest in semaglutide is driven largely by its ability to produce significant weight loss in many people who take it.
In the landmark STEP 1 trial published in the New England Journal of Medicine, adults with obesity who took the maximum 2.4 mg weekly semaglutide dose lost an average of around 15% of their body weight over 68 weeks.
Until recently, this level of weight loss was difficult to achieve without bariatric surgery.
Who Qualifies for Semaglutide Weight Loss Treatment?
In Canada, Wegovy is the only semaglutide product specifically approved for weight management.
It is officially approved for:
- Adults with a BMI of 30 or higher (obesity)
- Adults with a BMI of 27 or higher who have at least one weight-related condition (such as Type 2 diabetes or high blood pressure)
What About “Off-Label” Ozempic?
Even though Wegovy is the only brand officially approved for weight loss, doctors frequently prescribe Ozempic “off-label” for the exact same purpose.
This happens for two main practical reasons:
- Cost: Ozempic is often significantly more affordable out-of-pocket than Wegovy.
- Availability: Wegovy faced severe global supply shortages early on, leading doctors to rely on Ozempic instead.
If you are prescribed Ozempic for weight loss, rest assured, this is standard medical practice. Both pens contain the exact same active ingredient (semaglutide), which the latest Canadian clinical guidelines strongly recommend as a safe, highly effective option for long-term weight management.
Is There an Oral Semaglutide for Weight Loss?
A common question is whether the daily oral form (Rybelsus) can be used to avoid weekly injections. Officially, the answer in Canada is no — Rybelsus is currently approved only for Type 2 diabetes.
While a doctor may choose to prescribe Rybelsus off-label for a patient who absolutely cannot tolerate needles, expectations need to be managed. At its maximum approved dose of 14 mg, the weight loss from Rybelsus is modest compared to the injectable versions of semaglutide.
However, this might change in the future. Novo Nordisk has developed a 25 mg oral semaglutide tablet under the Wegovy brand specifically for weight management. In the OASIS 4 trial, this Wegovy pill produced roughly 17% average weight loss, which is comparable to injectable semaglutide. Novo Nordisk is expected to seek Canadian regulatory approval for oral Wegovy following its US launch.
Semaglutide vs Tirzepatide and Other GLP-1s
While there are several other weight loss medications currently in clinical trials, the primary alternative to semaglutide in Canada is a medication called tirzepatide. The semaglutide vs tirzepatide question comes up so often that it’s worth going into some detail on the topic.
Tirzepatide closely mirrors semaglutide in how it is approved and prescribed. Just as semaglutide is sold as Ozempic for diabetes and Wegovy for weight loss, tirzepatide is sold under the brand name Mounjaro for diabetes and Zepbound for weight loss.
Semaglutide and tirzepatide have some similarities, but they do not work in exactly the same way. While semaglutide only targets the GLP-1 receptor, tirzepatide is a “dual-action” medication that activates both GLP-1 and a second receptor called GIP.
In a head-to-head clinical trial comparing tirzepatide vs semaglutide, tirzepatide produced a higher average weight loss than semaglutide, although both were highly effective.
For a more detailed comparison between semaglutide and tirzepatide, see our article on Mounjaro vs Ozempic.
Semaglutide Side Effects
Whether you are taking the weekly injection or the daily pill, the side effects of semaglutide are broadly similar. Because the medication intentionally slows down how quickly food leaves your stomach, the most common side effects are overwhelmingly gastrointestinal.
The most frequently reported side effects from semaglutide include:
- Nausea
- Diarrhea
- Vomiting
- Constipation
- Upset stomach or heartburn
These symptoms tend to be most pronounced when you first start treatment or when you move up to a higher dose.
To minimize these risks, semaglutide dosing follows a process called “titration.” This simply means you will start on a very low dose and gradually increase it over several weeks or months, which gives your body time to adapt to the medication. For most patients, the gastrointestinal issues from semaglutide settle down within a few weeks.
Less Common and Serious Side Effects
While most people tolerate semaglutide well, there are some less common but more serious side effects to be aware of.
These can include:
- Gallbladder problems (like gallstones)
- Pancreatitis (inflammation of the pancreas)
- Dehydration from severe vomiting or diarrhea (which may cause secondary kidney issues if left unmanaged)
Additionally, semaglutide is not recommended for anyone with a personal or family history of medullary thyroid cancer or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Semaglutide Cost in Canada
The cost of semaglutide in Canada varies considerably depending on which product you’re prescribed, your insurance situation, and where you fill your prescription.
As a general guide, retail pricing for a one-month supply of semaglutide at a Canadian pharmacy can fall anywhere between $200 and $570. Ozempic and Rybelsus tend to sit on the lower end of that spectrum, while Wegovy is generally on the higher end.
Is Semaglutide Covered by Insurance?
Coverage depends entirely on what semaglutide is being prescribed for and what type of insurance you have:
- Public Drug Plans: Most provincial plans will cover Ozempic and Rybelsus if you have Type 2 diabetes (though your doctor will usually need to submit a special approval request). However, they rarely cover Wegovy for weight loss alone. While there have been recent recommendations to cover Wegovy for patients with a high risk of heart disease, provinces have been very slow to actually update their coverage.
- Private Insurance: Private health plans are generally more flexible. Many workplace or private plans now cover Wegovy with prior authorization, particularly if you meet specific BMI thresholds and are actively pursuing lifestyle changes alongside the medication.
For your individual situation, your doctor or pharmacist can give you a much more accurate estimate of semaglutide cost than any general guide.
Is Generic Semaglutide Available in Canada?
Generic semaglutide is on its way to Canadian pharmacies, but the timing remains uncertain.
Several major generic manufacturers have submitted applications to Health Canada to bring their own versions to market. Some companies are even technically clear to begin manufacturing generic semaglutide in Canada. However, because semaglutide is a complex injectable medication rather than a standard pill, the regulatory approval process is highly involved.
When generic semaglutide does arrive, prices are expected to drop significantly, which usually helps expand insurance coverage as well. Until then, brand-name Ozempic, Wegovy, and Rybelsus remain the only legitimately authorized semaglutide products available in Canada.
Compounded Semaglutide in Canada
Compounding is a practice where a pharmacy creates a custom medication for a specific patient need (such as an allergy to a standard ingredient). You may have seen “compounded semaglutide” advertised online, particularly in the United States. However, the rules in Canada are very different from the US.
In Canada, pharmacies are not legally permitted to produce compounded copies of commercially available drugs (like Ozempic or Wegovy). Provincial pharmacy regulators have explicitly instructed pharmacies not to compound semaglutide for weight loss, and Health Canada considers it unauthorized manufacturing.
There are real safety reasons behind this position. Compounded versions of semaglutide (and other medications) often rely on unregulated synthetic peptide powders sold as “research chemicals,” which are not subject to the same strict purity and quality controls as brand-name biologics.
For your safety, the only reliable path to semaglutide in Canada is through a licensed pharmacy dispensing an approved brand-name product.
How to Get Semaglutide in Canada
Semaglutide is a prescription-only medication in Canada.
Whether you’re looking at Ozempic, Wegovy, or Rybelsus, you’ll need to consult with a licensed Canadian physician. They can help you determine whether semaglutide is appropriate for you, which product and dose might be best, and monitor your progress over time.
Options for getting a prescription for semaglutide in Canada include your family doctor, an endocrinologist or obesity medicine specialist, or a virtual care platform like WalkIn that connects you with licensed Canadian doctors online.
Telemedicine consultations are particularly useful if you don’t have a family doctor or want to avoid waiting weeks for an appointment.
Frequently Asked Questions About Semaglutide
Is Ozempic the same as semaglutide?
Ozempic contains semaglutide as its active ingredient, but it’s only one of three semaglutide products available in Canada. Wegovy and Rybelsus also contain semaglutide, but at different doses and for different uses.
Can I take semaglutide as a pill instead of an injection?
Rybelsus is an oral semaglutide tablet approved in Canada for Type 2 diabetes. The daily semaglutide pills must be taken on an empty stomach, with strict fasting protocols required for proper absorption. Semaglutide pills are not approved for weight loss in Canada, although Rybelsus may be prescribed off-label for this purpose.
How much weight can I lose on semaglutide?
In clinical trials for Wegovy (the highest approved dose of semaglutide), participants lost an average of roughly 15% of their body weight over 68 weeks. However, individual results vary widely depending on the dose, duration of treatment, and lifestyle changes like diet and exercise.
Will I regain weight if I stop taking semaglutide?
Most people regain a significant portion of the weight they lost after stopping treatment. Canadian clinical practice guidelines explicitly recommend long-term pharmacotherapy for chronic weight management, treating obesity as a chronic disease rather than a short-term issue.
What’s the typical semaglutide dosage?
Semaglutide dosage depends on which product you’re prescribed and what it’s treating. Injectable Ozempic ranges from 0.25 mg to 2.0 mg weekly, Wegovy goes up to 2.4 mg weekly, and oral Rybelsus is taken at up to 14 mg daily. Whichever product you’re on, your doctor will start you at a low dose and gradually increase it.
Is generic semaglutide available in Canada yet?
As of writing, generic semaglutide is not yet on Canadian pharmacy shelves. Several manufacturers are progressing through Health Canada’s regulatory process, and generic versions are expected to become available in due course, though no specific launch date has been confirmed.
Is compounded semaglutide legal in Canada?
No. Provincial pharmacy regulators and Health Canada have strictly prohibited the mass-production of compounded semaglutide copies because safe, approved brand-name versions are already commercially available.
Is Semaglutide Right for You?
If you’re considering semaglutide for diabetes management or weight loss, the next step is a conversation with a Canadian healthcare provider who can review your medical history, weigh the benefits and risks for your situation, and recommend an appropriate treatment plan.
At Walk In, Canadian-licensed doctors are available for virtual consultations to assess your needs and discuss your treatment options from the comfort of your home. You don’t need to navigate this alone or sit on a waitlist to get clear, professional guidance on whether semaglutide is the right fit for you.
Speak With a Doctor About Semaglutide
Please note:
Walk In does not provide medical advice. The contents of this website, including text, graphics, images and any other material are intended for informational and educational purposes only and are not intended to substitute for professional medical advice, diagnosis or treatment. Although efforts are taken to keep any medical information on the website updated, we cannot guarantee that the information on our website is correct or reflects the most up-to-date medical information.
Please consult your physician for medical advice. Always seek the advice of a physician or other qualified healthcare provider with any questions regarding a medical condition. Never disregard or delay seeking professional medical advice or treatment because of something you have read on this website or on the internet.


